Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Synthroid Holding 75% Of Its Pre-Generic Script Share, Abbott Says

Sep 20 2004

• By Sue Sutter

Related Content

Synthroid, Levoxyl Generics Clear FDA; Sandoz Has Broadest Line

Jun 24 2004

Andrx Receives First Generic Approval For Abbott's Biaxin XL

Jun 25 2004

Abbott Will “Actively Promote” Synthroid Despite Generic Entrants

Jul 09 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window